Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.03 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |